Literature DB >> 9080473

Efficient production of high specific activity 64Cu using a biomedical cyclotron.

D W McCarthy1, R E Shefer, R E Klinkowstein, L A Bass, W H Margeneau, C S Cutler, C J Anderson, M J Welch.   

Abstract

Copper-64 (T 1/2 = 12.7 h) is an intermediate-lived positron-emitting radionuclide that is a useful radiotracer for positron emission tomography (PET) as well as a promising radiotherapy agent for the treatment for cancer. Currently, copper-64 suitable for biomedical studies is produced in the fast neutron flux trap (irradiation of zinc with fast neutrons) at the Missouri University Research Reactor. Access to the fast neutron flux trap is only possible on a weekly basis, making the availability of this tracer very limited. In order to significantly increase the availability of this intermediate-lived radiotracer, we have investigated and developed a method for the efficient production of high specific activity Cu-64 using a small biomedical cyclotron. It has been suggested that it may be possible to produce Cu-64 on a small biomedical cyclotron utilizing the 64Ni(p,n)64Cu nuclear reaction. We have irradiated both natural nickel and enriched (95% and 98%) Ni-64 plated on gold disks. Nickel has been electroplated successfully at thicknesses of approximately 20-300 mm and bombarded with proton currents of 15-45 microA. A special water-cooled target had been designed to facilitate the irradiations on a biomedical cyclotron up to 60 microA. We have shown that it is possible to separate Cu-64 from Ni-64 and other reaction byproducts rapidly and efficiently by using ion exchange chromatography. Production runs using 19-55 mg of 95% enriched Ni-64 have yielded 150-600 mCi of Cu-64 (2.3-5.0 mCi/microAh) with specific activities of 94-310 mci/microgram Cu. The cyclotron produced Cu-64 had been used to radiolabel PTSM [pyruvaldehyde bis-(N4-methylthiosemicarbazone), used to quantify myocardial, cerebral, renal, and tumor blood flow], MAb 1A3 [monoclonal antibody MAb to colon cancer], and octreotide. A recycling technique for the costly Ni-64 target material has been developed. This technique allows the nickel eluted off the column to be recovered and reused in the electroplating of new targets with an overall efficiency of greater than 90%.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9080473     DOI: 10.1016/s0969-8051(96)00157-6

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  132 in total

1.  Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.

Authors:  Yunjun Guo; Riccardo Ferdani; Carolyn J Anderson
Journal:  Bioconjug Chem       Date:  2012-06-18       Impact factor: 4.774

2.  Evaluation of multivalent, functional polymeric nanoparticles for imaging applications.

Authors:  Monica Shokeen; Eric D Pressly; Aviv Hagooly; Alexander Zheleznyak; Nicholas Ramos; Ashley L Fiamengo; Michael J Welch; Craig J Hawker; Carolyn J Anderson
Journal:  ACS Nano       Date:  2011-01-28       Impact factor: 15.881

3.  A lariat-functionalized copper(II) diimine-dioxime complex.

Authors:  Salma Kiani; Richard J Staples; Alan B Packard
Journal:  Acta Crystallogr C       Date:  2002-11-20       Impact factor: 1.172

4.  In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.

Authors:  Jeffrey M Craft; Ravindra A De Silva; Kimberly A Lears; Rebecca Andrews; Kexian Liang; Samuel Achilefu; Buck E Rogers
Journal:  Nucl Med Biol       Date:  2012-01-20       Impact factor: 2.408

Review 5.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

6.  Cyclotron Production of High-Specific Activity 55Co and In Vivo Evaluation of the Stability of 55Co Metal-Chelate-Peptide Complexes.

Authors:  Tara Mastren; Bernadette V Marquez; Deborah E Sultan; Elizabeth Bollinger; Paul Eisenbeis; Tom Voller; Suzanne E Lapi
Journal:  Mol Imaging       Date:  2015       Impact factor: 4.488

7.  Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT.

Authors:  Sabrina H L Hoffmann; Andreas Maurer; Dorothea I Reck; Gerald Reischl; Bernd J Pichler; Manfred Kneilling; Christoph M Griessinger
Journal:  J Vis Exp       Date:  2017-04-29       Impact factor: 1.355

8.  Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

Authors:  Lihui Wei; Yubin Miao; Fabio Gallazzi; Thomas P Quinn; Michael J Welch; Amy L Vāvere; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2007-09-04       Impact factor: 2.408

9.  Copper-64 labeled liposomes for imaging bone marrow.

Authors:  Sang-Gyu Lee; Kishore Gangangari; Teja Muralidhar Kalidindi; Blesida Punzalan; Steven M Larson; Naga Vara Kishore Pillarsetty
Journal:  Nucl Med Biol       Date:  2016-08-27       Impact factor: 2.408

10.  Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET.

Authors:  Yongjian Liu; Dana Abendschein; Geoffrey E Woodard; Raffaella Rossin; Kyle McCommis; Jie Zheng; Michael J Welch; Pamela K Woodard
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.